Poster presented at BTS 2017 in London, UK.

Download poster


Posted in Presented Research, AeroChamber Plus* Flow-Vu* Chamber, asthma, COPD

Aerobika* device proves to be a cost-effective treatment option in the management of post-exacerbation COPD patients.

Posted in News, Aerobika*, COPD

Did you know that cold air can worsen your Chronic Obstructive Pulmonary Disease (COPD) symptoms?

When cold air (especially cold, dry air) enters the lungs it can cause the airways to constrict, resulting in shortness of breath and flare-ups of COPD symptoms. The good news is that these effects can be avoided by checking the weather forecast and planning ahead. If you need to go out into the cold weather, here are some tips that may help.

Posted in News, Aerobika*, COPD

November is Lung Health Month

Lung Health Month is an opportunity to raise awareness for respiratory diseases and learn more about how we can protect our lungs.

Learn more about how you can protect your breathing...

Posted in Events, asthma, COPD

Chronic Obstructive Pulmonary Disease (COPD) is a significant healthcare problem, with an estimated 384 million cases worldwide in 2010.1 Population aging is predicted to drive further growth, with one study forecasting a 150% increase in prevalence overall, and up to 220% in the 75 and over age group, between 2010 and 2030.

Posted in Press, News, COPD, AeroCount*, AEROECLIPSE*
Posted in Presented Research, AeroChamber Plus* Flow-Vu* Chamber, asthma, COPD

Treatment with the Aerobika* device can significantly reduce the recurrence of exacerbations of COPD in the crucial 30-day period following hospitalization or emergency room visits, according to a study published this month in Pulmonary Therapy.

Posted in News, Aerobika*, COPD

Oscillating positive expiratory pressure (OPEP) devices may reduce chronic symptoms in patients with obstructive pulmonary disease (COPD); however, no real-world studies have been performed to evaluate the benefits of these devices. The objective of this study was to measure the rate of early (30-day) moderate-to-severe exacerbations and related costs in COPD patients treated with Aerobika*, an OPEP device, vs. a matched control group in a real-world setting.

Posted in Published Studies, Aerobika*, COPD

A recent study by Western University researchers, published in the Journal of Chronic Obstructive Pulmonary Disease, reveals that the use of the Aerobika® device, has a significant impact on quality of life for study patients suffering from chronic bronchitis, a disease that accounts for almost 70% of Chronic Obstructive Pulmonary Disease (COPD) diagnoses globally.[1] These study results show significan

Posted in News, Aerobika*, COPD

The AeroChamber* Brand of Valved Holding Chamber (VHC) has been continually updated and improved upon since it was first introduced in 1983. The product enhancements are designed to increase ease of use for patients while enhancing the consistency of aerosol medication delivery.

Posted in Published Studies, asthma, COPD